Meta-Analysis of Three Randomized Trials and Nine Observational Studies Comparing Drug-Eluting Stents Versus Coronary Artery Bypass Grafting for Unprotected Left Main Coronary Artery Disease-Reference-Cited by-同舟云学术

Meta-Analysis of Three Randomized Trials and Nine Observational Studies Comparing Drug-Eluting Stents Versus Coronary Artery Bypass Grafting for Unprotected Left Main Coronary Artery Disease

Published:2012-11 Issue:10 Volume:110 Page:1411-1418
ISSN:0002-9149
Container-title:The American Journal of Cardiology
language:en
Short-container-title:The American Journal of Cardiology

Author:

Jang Jae-Sik,Choi Kyu-Nam,Jin Han-Young,Seo Jeong-Sook,Yang Tae-Hyun,Kim Dae-Kyeong,Kim Dong-Soo,Urm Sang-Hwa,Chun Jin Ho,Kang Soo-Jin,Park Duk-Woo,Lee Seung-Whan,Kim Young-Hak,Lee Cheol Whan,Park Seong-Wook,Park Seung-Jung

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference28 articles.

1. Effect of coronary bypass surgery on survival patterns in subsets of patients with left main coronary artery disease;Chaitman;Am J Cardiol,1981

2. Comparison of surgical and medical group survival in patients with left main equivalent coronary artery disease;Caracciolo;Circulation,1995

3. ACCF/SCAI/STS/AATS/AHA/ASNC 2009 Appropriateness Criteria for Coronary Revascularization

4. Percutaneous treatment with drug-eluting stent implantation versus bypass surgery for unprotected left main stenosis: a single-center experience;Chieffo;Circulation,2006

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety and efficacy of percutaneous coronary intervention versus coronary artery bypass graft in patients with STEMI and unprotected left main stem disease: A systematic review & meta-analysis;IJC Heart & Vasculature;2022-06

2. Age-Stratified Outcome in Treatment of Left Main Coronary Artery Stenosis: A NOBLE Trial Substudy;Cardiology;2021

3. Nonemergent Percutaneous Coronary Intervention on an Unprotected Left Main Coronary Artery Supported with Impella® Heart Pump in Patients Ineligible for Surgical Revascularization;Journal of Interventional Cardiology;2019-06-04

4. Combination of transarterial chemoembolization and sorafenib improves outcomes of unresectable hepatocellular carcinoma: an updated systematic review and meta-analysis;Japanese Journal of Clinical Oncology;2018-09-29

5. Percutaneous coronary intervention with drug-eluting stent versus coronary artery bypass grafting: A meta-analysis of patients with left main coronary artery disease;International Journal of Cardiology;2017-12